Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
NBRV was delisted on the 31st of July, 2023.
21 hedge funds and large institutions have $195M invested in Nabriva Therapeutics plc Ordinary Shares Ireland in 2015 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 5 increasing their positions, 6 reducing their positions, and 3 closing their positions.
115% more capital invested
Capital invested by funds: $90.6M → $195M (+$104M)
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
100% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 3
17% more funds holding
Funds holding: 18 → 21 (+3)
17% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 6
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
+$2.94M |
| 2 |
OM
Opaleye Management
Boston,
Massachusetts
|
+$2.15M |
| 3 |
ACP
Acuta Capital Partners
Redwood City,
California
|
+$600K |
| 4 |
USAA
United Services Automobile Association
San Antonio,
Texas
|
+$210K |
| 5 |
PC
Polar Capital
London,
United Kingdom
|
+$107K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HCMT
Highland Capital Management (Texas)
Dallas,
Texas
|
-$2.76M |
| 2 |
RSCM
Rock Springs Capital Management
Baltimore,
Maryland
|
-$873K |
| 3 |
Alyeska Investment Group
Chicago,
Illinois
|
-$499K |
| 4 |
WT
Wellcome Trust
London,
United Kingdom
|
-$359K |
| 5 |
LCM
Laurion Capital Management
New York
|
-$255K |
NBRV Hedge Fund Activity: Q4 2015 in Review
21 of the 3,824 institutional investors tracked by Wall St. Rank reported a position in Nabriva Therapeutics plc Ordinary Shares Ireland (NBRV) for Q4 2015, worth a combined $195M — up 115% from $90.6M a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new NBRV positions and 3 closed out — a net gain of 3 holders — while 5 added to existing stakes and 6 trimmed.
The largest buyer was Wellington Management Group, adding an estimated $2.94M. The largest seller was Highland Capital Management (Texas), exiting entirely with an estimated $2.76M sold.
- 21 institutional investors held Nabriva Therapeutics plc Ordinary Shares Ireland (NBRV) as of Q4 2015, up from 18 in Q3 2015.
- Funds reported $195M of Nabriva Therapeutics plc Ordinary Shares Ireland stock for Q4 2015, up 115% quarter-over-quarter.
- 6 funds opened new Nabriva Therapeutics plc Ordinary Shares Ireland positions in Q4 2015 and 3 closed out, a net change of +3 holders.
- The largest Nabriva Therapeutics plc Ordinary Shares Ireland buyer in Q4 2015 was Wellington Management Group, an estimated $2.94M added.
- The largest Nabriva Therapeutics plc Ordinary Shares Ireland seller in Q4 2015 was Highland Capital Management (Texas), an estimated $2.76M sold.
Based on aggregated 13F filings for Q4 2015.